• Net sales reached SEK 17.2 million (15.8). • The operating result totaled SEK -13.7 million (-13.8). • Earnings per share, basic and diluted, were SEK -0.05 (-0.09). • Cash flow from ...
Enzymatica AB (publ), a life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract. The company’s product includes ColdZyme ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
• Net sales reached SEK 17.2 million (15.8). • The operating result totaled SEK -13.7 million (-13.8). • Earnings per share, basic and diluted, were SEK -0.05 (-0.09). • Cash flow from ...
• Net sales reached SEK 17.2 million (15.8). • The operating result totaled SEK -13.7 million (-13.8). • Earnings per share, basic and diluted, were SEK -0.05 (-0.09). • Cash flow from operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback